OUR HISTORY

1997
Foundation
1997
First EU GMP artesunate: Arinate®
First β-Artemether: Artemether® 80mg/ml
2000
First EU GMP pediatric suspension: Artesiane®
2000
2002
First artemisinin-based combination therapy marketed: Ariplus®
2002
2003
First Co-Arinate® co-blister
2003
2004
First artemisinin-based combination therapy paediatric suspension: Co-Artesiane®
2004
2005
Move to our current headquarters in Turnhout
2005
2006
First FDC marketed: Co-Arinate®
2006
2008
Start portfolio diversification program
2008
2009
Dafra Pharma Swiss subsidiary for warehousing and logistics
2009
2011
100 sales representatives in Africa
2011
2013
Passing away of founder / R&D director / president Dr. Frans Herwig Jansen
2013
2014
Introduction CRM system African sales forces
2014
2017
20 years Dafra Pharma
2017
175 sales representatives in Africa
2018
First RID (Rencontres Internationales Dafra)
2018
2018
Introduction of our online education system: DAM (Dafra Academy Medical) for our African sales forces
2018
2020
Well-balanced product portfolio
2020
2020
Excellence Dafra Togo: eloquence and scientific communication competition
2020
2020
> 200 sales representatives in Africa
2020
2020
First online RID (Rencontres Internationales Dafra)
2020
2021
Introduction CRM 2.0 for our African sales forces
2021
2021
Excellence Dafra Ivory Coast: eloquence and scientific communication competition
2021
2021
Excellence Dafra Togo 2.0: eloquence and scientific communication competition
2021
2021
Excellence Dafra Cameroon: eloquence and scientific communication competition
2021
2021
Excellence Dafra Benin: eloquence and scientific communication competition
2021